The Patient Protection and Affordable Care Act provides incentives and flexibility for employees to participate in workplace wellness programs offered by their group health plans.
But some employer groups are objecting to certain provisions of a final rule (PDF) issued today by HHS, the Internal Revenue Service, and the Labor and Treasury departments that provides incentives for nondiscriminatory wellness programs. They contend that the rule imposes an excessive burden on employers to provide flexibility to employees for their participation and how they qualify for financial rewards.
Read the full story here: http://bit.ly/16scVkp
Source: Modern Healthcare
Under the rule, wellness programs are divided into two major categories: participation-based and health-contingent. The first type is available to everyone under a group health plan regardless of their health status. These include programs that reimburse for the cost of gym membership or reward employees who participate in an online health education program, without requiring them to take further action.
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Patients With Advanced, Recurrent Melanoma May Experience Lasting AEs From ICM Therapy
May 9th 2024A cross-sectional, mixed-methods study found that adverse effects (AEs) can occur even after 1 year of treatment with immune checkpoint modulator (ICM) therapy in patients with melanoma.
Read More